Objective. To prioritize performance measures for colorectal cancer care to facilitate the implementation of a pay-for-performance (PFP) system.
Introduction
Performance measurement currently serves as a core element in the health-care industry for determining the care services that providers deliver to patients and what actions may be anticipated to improve the quality of care delivery in the future [1] . As increasingly more pay-for-performance (PFP) scheme and public disclosure initiatives have been established around the world, much enthusiasm has been shown for ranking performance. Both PFP and public disclosure often require data on rankings and composite scores because the public or authorities can use this information to make subsequent decisions. Studies also have shown that PFP and the public disclosure of such information might lead to a significant and positive effect on quality in the health-care market [2, 3] .
In Taiwan, PFP schemes have been implemented for five major diseases (diabetes, tuberculosis, asthma, cervical cancer and breast cancer) since 2001 [3] . The success of these schemes has provided the government with the impetus to incorporate PFP into the management of a wider range of diseases in the near future to contain costs because health insurance in Taiwan is provided by a single payer governed by the administration [1] . Among the candidate diseases, colorectal cancer represents a major public health concern and is the third leading cause of cancer deaths in Taiwan [4] . Although multiple chemotherapeutic agents and other modalities are currently available for adjuvant treatments of advanced disease, several studies have demonstrated discernible variation in patients with similar condition [5 -7] .
This was a pilot study to determine the priorities given to performance measures in colorectal cancer care using the analytic hierarchy process (AHP). We aimed to identify best performance measures for all candidates and the priorities for these measures. The advantages afforded by the study include not only the provision of a suitable performance measurement tool for colorectal cancer care from the professional point of view but also the ranking of these measures in a scientific manner for decision makers, especially for PFP and public disclosure.
Methods

Selection of initial quality measure set
Before conducting the AHP questionnaire survey, we first comprehensively reviewed the literatures on performance measures of colorectal cancer care. Special attention was paid to measures that were described as ideal, practical and important for identifying appropriate performance scores (see Fig. 1 ). This study followed on from our previous core measure project on measures [1] , which is depicted in the upper half of Fig. 1 . We selected measures that were general (dealing with a broader range of care procedures), rather than technical ( pertaining to specific details of a given procedure), and these were modified to allow for binary status assignment (yes/no, concordant/non-concordant). The selection criteria for these candidate measures were divided into three categories: importance and necessity, scientific acceptability and usability [8] . Initially, 122 measures were included in the selection list. In 2009, we updated these measures and selected a final set of performance measures to design a PFP scheme for implementation in colorectal cancer care (lower half of Fig. 1 ). This endeavor was completed in collaboration with nationwide professional experts from appropriate specialty societies (nominated by the Taiwan Clinical Oncology Group from the National Health Research Institute). After two rounds of face-to-face discussions with experts, 11 measures were recommended, including two pre-treatment (PT), six treatment (T) and three follow-up (F) measures. The numerator, denominator and rationale for each performance measures are described in Table 1. The rationale for PT1, PT2 and T1 emphasizes proper pre-operative examinations or screening while that for T2 and T6 emphasizes the timeliness of treatment. The essence of T3, T4 and T5 is mainly to demonstrate the accountability of surgeons or pathologists. Measures F1, F2 and F3 provide for the surveillance of outcomes.
Analytic hierarchy process
The AHP was developed by Thomas L. Saaty to solve complex problems involving multiple criteria [9] . It has been accepted by the international scientific community as a robust and flexible multi-criteria decision-making (MCDM) tool to deal with complex decision problems [10, 11] . A major advantage of AHP is in the formalization of the structuring and assessment of all the factors and their interactions in a decision domain. AHP has three underlying concepts: structuring the complex decision problem as a hierarchy of goal, criteria and alternatives pair-wise comparison of the elements at each level of the hierarchy with respect to each criterion of the preceding level and vertically synthesizing the judgments over the different levels of the hierarchy [12] . The fundamental scales for pair-wise comparison ranged from 1 (equal intensity) to 9 (extremely higher intensity). The comparison matrix based on specialists' preferences provides an eigenvector (weight), and an eigenvalue (maximum eigenvalue, lmax), the consistency of which can be checked. The consistency index (CI ¼ lmax-n/n-1, n ¼ number) and consistency ratio [CR ¼ CI/RI, random index (RI)] should be less than 0.1 (RI ¼ 0, when n ¼ 2, RI ¼ 0.58, when n ¼ 3, RI ¼ 1.24, when n ¼ 6). The matrix is not calculated if CI or CR is .0.1. An overall priority for the indicators can be obtained by combining the weighted decision elements [9] . The AHP method finally provides a priority ranking of all alternatives in terms of their overall preferences.
AHP questionnaire
We assigned four-level hierarchy in the AHP questionnaire as a conceptual framework to determine the priority of performance measures (level 1: set; level 2: clinical category of measurement; level 3: performance measures; level 4: rating dimension, see Fig. 2 ). From this framework, the questionnaire that includes 11 measures yielded 63 pair-wise comparisons as the basis of AHP is an ordinal pair-wise comparison of attributes (see Supplementary data, Appendix 1). The selection category included three aspects: importance and necessity, scientific acceptability and usability. Importance and necessity indicated whether the performance measure was important and necessary to colorectal cancer care. Scientific acceptability indicated whether there was strong evidence that this indicator was a performance measure. Usability indicated that the application of the indicator could help to facilitate changes or improvements in physician's behavior [8, 13] . The AHP questionnaires on the comparison of these measures were mailed to experts nominated by each related specialty society (e.g. the Taiwan Surgical Association, the Taiwan Surgical Society of Gastroenterology, the Society of Colon and Rectal Surgeons, the Gastroenterological Society of Taiwan, the Taiwan Society of Internal Medicine, the Chinese Oncology Society, the Taiwan Society of Therapeutic Radiation and Oncology and the Taiwan Society of Pathology) on 5
November 2009 and were collected from 10 December 2009 onward. We contacted all experts by telephones or e-mails to obtain their approval before mailing the AHP questionnaires. 
Results
Descriptive statistics of AHP expert questionnaires
We mailed 66 questionnaires to 32 surgeons and 34 physicians, and 48 were returned giving a response rate of 72.7% (48/66). The effective response rate was 69.7% because two responses were excluded due to inconsistencies. Table 2 summarizes the characteristics of respondents. Female doctors were in the minority (male/female: 46/2). Among the valid respondents, about 72% worked in medical centers, and about 94% were over 40 years of age and possessed more than 10 years experiences in their specialty. Half (54.5%) of the respondents served as the chief or director of their departments. The number of surgeons and non-surgeons among respondents was similar (24) . About 83.3% (40/48) of the respondents agreed that the weight for each performance measure should not be equal (i.e. prioritization was necessary). Only 16.7% of respondents overlooked the necessity of priority. Furthermore, nearly all respondents agreed that measures should be renewed after a certain period of time: 43.8% respondents advocated an interval of 3-5 years, 27.1% respondents advocated 5 -10 years and 25.0% respondents advocated ,3 years.
AHP indicator priorities
According to valid respondents, the priority of treatment category obviously overweights that of follow-up category and PT category. Table 3 displays the priorities of each indicator in terms of importance and necessity, scientific acceptability, and usability and global priorities. Importance and necessity, scientific acceptability and usability represent the rating dimensions, whereas global priority is the sum of local priority of each measure according to the weights of these three dimensions. For importance and necessity, the highest priority of performance measures was PT1 ( preoperative check-up with CXR, abdominal ultrasound, computed tomogram scan or MRI), followed by T3 ( pathologic confirmation of negative margins for stages I-III patients) and T4 ( pathologic report of tumor size, differentiation and lymph node status). The lowest priority of performance measures was T1 (examination of colonoscopy or lower gastrointestinal series within 6 months perioperatively). For scientific acceptability and data usability, priorities and ranks fluctuated with minimal scales. First three rank and last rank measures are identical to that result from dimension of importance and necessity.
Based on the priority of rating dimension (importance and necessity: 0.397; scientific acceptability: 0.315; data usability: 0.288, respectively) from this AHP survey, it yielded global priority pertaining individual performance measure. Summation of global priorities of individual performance measure equals to one. The highest global priority of performance measure was PT1 (global priority ¼ 0.144), followed by T3 (global priority ¼ 0.133), T4 (global priority ¼ 0.116), PT2 ( percentage of patients with early stage of colorectal cancer, global priority ¼ 0.104), F1 (5 years survival rate of stages I-IV, global priority ¼ 0.101) and T5 (for patients with stages I-III disease, examination of lymph nodes should !12 in number, global priority ¼ 0.092). The least global priority of these performance measures was T1 (global priority ¼ 0.030).
Discussion
With the soaring expenditure in health-care delivery and the expectation of divergence between health-care quality and expense, the implementation or extension of PFP programs in a wide range of fields (e.g. cancer domains) may be the clue to solve this dilemma. This study explored and determined the priorities of possible performance measures for colorectal cancer care to design a PFP program. We used the AHP technique to provide an infrastructure for the decomposition of a complex decision into a hierarchy fashion of various measures and thus acquired the priorities of candidate measures. Although most medical professionals had not been familiar with the AHP technique, these specialists expressed their concerns, made suggestions and gave their expertise regarding the PFP program in colorectal cancer care partially because the study was intended to offer recommendations to policymakers and, therefore, might affect reimbursements to health-care organization. For example, they suggested that these performance measures should be updated after a certain period (e.g. 5 years) and that process measures should be implemented first. In parallel with performance measures for breast cancer [8] , multidisciplinary involvement was also advocated for colorectal cancer care. With regard to the specific indicator T5 that recommended a minimal requirement of an examination of 12 lymph nodes, some respondents were concerned with whether this standard could easily be achieved. All these findings revealed that the application of AHP is not only promising in cancer care but also ensures rational contributions from medical specialists to the domain of quality improvement programs such as PFP.
To reward health-care providers for high levels of quality and quality improvements in care quality, PFP has been accepted and implemented in the health-care systems of many countries [3] . In a recent review of 64 conceptual papers on PFP, van Herck et al. had proposed a model for implementing and monitoring incentive quality as a guide to designing and implementing PFP in a practical structured way. In contrast to the four phases (contemplation, design, implementation and evaluation) proposed by the Agency for Healthcare Research and Quality, they designed five phases (quality of care, incentives, communication, implementation and evaluation) as a step-by-step framework for PFP [14] . Among the five phases of PFP cycle proposed by van Herck et al., our study was relative to the 'quality of care' and 'incentive' phases.
The selection of performance measures for PFP can be made using existing databases such as the National Quality Measurement Clearinghouse (NQMC), evidence-based medicine, literatures reviews or related studies and consensus meetings that provide faster and more educated choices [15, 16] . However, the number of ideal performance measures for quality cancer care is usually large and is impractical for subsequent implementation of PFP. Researchers, therefore, need to select a set of potential candidates in advance so that the incorporation of expert opinions using AHP technique into the setting of priorities for performance measures of cancer care is feasible and reasonable. In contrast, medical professionals often play an important role in quality improvement programs, and processes such as expert participation in the AHP project may mitigate the hindrance of clinicians' attitudes toward the conflicts of interests and promote the quality of cancer care and hence pave the way for authorities to disseminate cancer care improvement campaigns nationwide. The most important contribution of the AHP technique toward the implementation of PFP, thus, obviously includes not only the provision of scientific priorities using hierarchical structure for each measure to facilitate the design of PFP, but also mitigation of a mechanism that can stall the quality improvement program insidiously. The AHP technique has been applied empirically to several medical conditions and in health-care decision making since its conception [17] . Although the conditions involved included diagnosis, patient participation, therapy, transplantation, evaluation of technology, human resources planning and health-care evaluation [17] , the application of AHP in the field of cancer care domain has been limited. Dolan and his colleagues reported their experiences of AHP analysis in a colorectal cancer screening program [18 -20] . However, the use of AHP to prioritize performance measures of cancer care in the pursuit of implementing PFP has not been reported previously.
Most performance measures of colorectal cancer care we used in this study originated from our previous study [1] . But the number of measures was tailored to facilitate the introduction of the AHP technique. The only measure added from our prior study was PT2 ( percentage of early colorectal cancer), which underlined screening and early diagnosis. Before the target measure was selected, it went through fierce debate during the expert meetings. Worries of these experts arose from concerns of possible reduction in reimbursement (or financial punishment), if this finally became a formal measure because there is a strong likelihood that more advanced cancer patients will be treated in medical centers as a consequence of global budget (i.e. increased costs but fixed reimbursements). Such would create a barrier for medical centers to participate in PFP programs because they provide more sophisticated cancer care services. We also noticed that rankings among these performance measures only fluctuated little with regard to different rating dimensions. This might reflect either the stability, robustness of these measures or the ignorance and indifference of respondents to the focus of rating dimension. A single global priority rating, therefore, probably suffices to provide informative decision making as to colorectal cancer care.
In addition to the AHP technique, several methods or techniques are frequently used and can be served to prioritize measures, such as the analytic network process (ANP), fuzzy AHP, the modified Delphi method and factor analysis. Conducting a questionnaire survey is indispensable for all of these techniques, except for factor analysis. Factor analysis, a Figure 2 Conceptual framework of AHP model for performance measurement of colorectal cancer. method used to uncover latent structure, can estimate factor loading (weight) for each measures [21] . Because the weight of each measure was derived from empirical data collected by researcher, the variability of the study group may profoundly influence the weight of each measure in factor analysis. In other words, the outlier is very sensitive in factor analysis, especially when the study size is relatively small. The ANP is a variant form of AHP, has a more complicated questionnaire and is more time consuming in its computation as it takes into consideration all criteria and alternatives simultaneously [22] . Fuzzy AHP, another variant of AHP, is a hybrid of combined fuzzy theory and AHP and aims to allow for uncertainty in the human preference model [23] . It delineates a range of preferences for a certain measure rather than the crisp value of preference provided by the AHP technique. Fuzzy AHP, ANP and AHP are all MCDM analysis, a group of methodology that helps to incorporate multiple conflicting criteria or sub-criteria formally incorporated into the management planning process.
The [25, 26] . Thus, investigators are equipped with more methodological alternatives to resolve the problem of MCDM. We acknowledged that there were several limitations regarding this study. First, the structure of AHP (especially only six measures were selected for T in level 2) was limited due to the AHP questionnaire itself. Too many measures (e.g. seven measures) might make a perfect pair-wise comparison of performance measures difficult for participants [27] . In future, development of performance measures in other domains may require precaution when the AHP technique is considered. Second, the AHP technique offered less opportunity to consider uncertainty when experts were deciding on their preferences. When this is a major concern, fuzzy AHP might present a better solution to address this limitation. Third, because each respondent represented a specialty society, this might introduce bias in the determination of priorities for these performance measures. Although we tried to standardize the variables, our results should be interpreted with caution in recognition of the possible reference bias.
Conclusions
In conclusion, although the complexity of the AHP questionnaire was alien to most medical professionals, the response rate was high. Medical professionals were interested in participating in performance measurement related to their fields. The results emphasized the importance of pre-operative examinations and pathologic information during cancer care. If the aim of a PFP system is to improve the quality of patient care, the dedication of medical professionals becomes increasingly important. We suggested that the AHP method might be a good alternative for setting the priorities of performance indicators, especially in a highly specialized domain (i.e. colorectal cancer care). 
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